Outcome (alpha) | Â | Mean (95% CI) | ||||||
---|---|---|---|---|---|---|---|---|
Baseline | Â | Endline | 3-month follow-up | |||||
EASE (N = 35) | ETAU (N = 32) | EASE (N = 35) | ETAU (N = 32) | d | EASE (N = 35) | ETAU (N = 32) | d | |
PSC (α = 0.78) | 20.4 (17.2, 23.5) | 21.0 (17.0, 25.0) | 21.0 (17.8, 24.2) | 20.7 (16.7, 24.6) | 0.12 | 21.3 (18.2, 24.5) | 20.3 (16.3, 24.2) | 0.21 |
PHQ (α = 0.77) | 5.2 (3.4, 7.0) | 5.4 (3.1, 7.7) | 5.3 (3.5, 7.1) | 5.1 (2.8, 7.4) | 0.10 | 5.0 (3.2, 6.8) | 5.6 (3.3, 7.9) | -0.08 |
CRIES (α = 0.78) | 21.9 (17.0, 26.7) | 20.9 (15.0, 26.8) | 22.7 (17.8, 27.5) | 20.8 (15.0, 26.7) | 0.07 | 19.2 (14.3, 24.0) | 23.9 (18.0, 29.8) | -0.44 |
Functioning (α = 0.79) | 6.4 (4.0, 8.8) | 6.9 (3.8, 10.0) | 5.8 (3.4 8.2) | 7.4 (4.3, 10.5) | -0.18 | 6.7 (4.3, 9.1) | 6.1 (2.9, 9.2) | 0.18 |
Wellbeing^ (α = 0.83) | 46.3 (43.0, 49.6) | 46.4 (43.0, 49.8) | 48.8 (45.6, 52.1) | 49.9 (46.5, 53.3) | -0.10 | 43.6 (40.3, 46.9) | 44.1 (40.7, 47.6) | -0.05 |